ALLARITY THERAPEUTICS, INC.

Consensus Allarity Therapeutics, Inc.

Stocks

ALLR

US0167445008

Biotechnology & Medical Research

Market Closed - Nasdaq 00:00:00 12/09/2026 +04			5-day change	1st Jan Change
1.220 ^USD	-2.40%		-14.08%	+12.96%

08-14	Tranche Update on Allarity Therapeutics, Inc.'s Equity Buyback Plan announced on March 30, 2026.	CI
08-14	Allarity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Evolution of the Average Target: Allarity Therapeutics, Inc.

Evolution of the Target Price: Allarity Therapeutics, Inc.

Changes in Analyst Recommendations: Allarity Therapeutics, Inc.

090ce50350802.bIlrftKm2yJoo0mxFGOoMRCPCpaXfKuOcnibgXzCkVc.IdkTBuPx4xQg6DngWhL8aEr1QNrcN_nCITPcuBqN8gVa0F0m4-qEVCPnDA~0d1360679dbb4cf77061ee5577352405

Analysts' recommendations: Allarity Therapeutics, Inc.

23/08/22	Ladenburg Thalmann Downgrades Allarity Therapeutics to Neutral From Buy	MT
27/05/22	Ladenburg Thalmann Initiates Allarity Therapeutics at Buy with $8 Price Target	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALLARITY THERAPEUTICS, INC.			-	-	+740.16%
	WUXI APPTEC CO., LTD.					+23.69%
	ARGENX SE					+18.14%
	INSMED INCORPORATED					+54.69%
	WUXI BIOLOGICS (CAYMAN) INC.					+23.66%
	BIONTECH SE					+23.2%
	GENMAB A/S					+17.29%
	PHARMAESSENTIA CORPORATION					+9.16%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+32.94%
	EXELIXIS, INC.					-4.33%
	Average					+93.86%
	Weighted average by Cap.					+23.35%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.220USD

Average target price

10.25USD

Spread / Average Target

+740.16%

High Price Target

10.25USD

Spread / Highest target

+740.16%

Low Price Target

10.25USD

Spread / Lowest Target

+740.16%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALLR Stock
Consensus Allarity Therapeutics, Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!